A sign is seen at an AstraZeneca site in Macclesfield, central England April 28, 2014. U.S. drugmaker Pfizer Inc is working on its next move in a potential $100 billion bid battle for Britain's ... more 
A sign is seen at an AstraZeneca site in Macclesfield, central England April 28, 2014. U.S. drugmaker Pfizer Inc is working on its next move in a potential $100 billion bid battle for Britain's AstraZeneca Plc after having a two bids rejected, as deal-making grips the healthcare industry. Pfizer said on Monday it made a 58.8 billion pounds ($98.9 billion) bid approach to AstraZeneca in January and had contacted its British rival again on April 26 seeking further discussions about a takeover. REUTERS/Darren Staples (BRITAIN - Tags: BUSINESS HEALTH) less 
1 / 17
Reuters | Photo By DARREN STAPLES / REUTERS
Mon, Apr 28, 2014 9:24 AM EDT